Showing results (11-20 of 30) with videos related to
Sort By:
Pageof 3
Current Topics in Medicinal Chemistry|October 18, 2014
Design, synthesis and screening studies of potent thiazol-2-amine derivatives as fibroblast growth factor receptor 1 inhibitorsB V S Suneel Kumar, Narasu Lakshmi, M Ravi Kumar, et al.Nature Communications|October 6, 2016
Mechanistic evaluation and transcriptional signature of a glutathione S-transferase omega 1 inhibitorKavya Ramkumar, Soma Samanta, Anahita Kyani, et al.Cancer & Metabolism|September 24, 2021
Targeting MYC-enhanced glycolysis for the treatment of small cell lung cancerKasey R Cargill, C Allison Stewart, Elizabeth M Park, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 8, 2023
Targeting BCL2 Overcomes Resistance and Augments Response to Aurora Kinase B Inhibition by AZD2811 in Small Cell Lung CancerKavya Ramkumar, Azusa Tanimoto, Carminia M Della Corte, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 31, 2019
Combination Treatment of the Oral CHK1 Inhibitor, SRA737, and Low-Dose Gemcitabine Enhances the Effect of Programmed Death Ligand 1 Blockade by Modulating the Immune Microenvironment in SCLCTriparna Sen, Carminia M Della Corte, Snezana Milutinovic, et al.Molecular Cancer Research : MCR|November 11, 2020
AXL Inhibition Induces DNA Damage and Replication Stress in Non-Small Cell Lung Cancer Cells and Promotes Sensitivity to ATR InhibitorsKavya Ramkumar, C Allison Stewart, Kasey R Cargill, et al.Journal of Experimental & Clinical Cancer Research : CR|March 29, 2022
Anti-tumor activity of cetuximab plus avelumab in non-small cell lung cancer patients involves innate immunity activation: findings from the CAVE-Lung trialCarminia Maria Della Corte, Morena Fasano, Vincenza Ciaramella, et al.Journal of Translational Medicine|November 24, 2022
Triple blockade of Ido-1, PD-L1 and MEK as a potential therapeutic strategy in NSCLCCarminia Maria Della Corte, Vincenza Ciaramella, Kavya Ramkumar, et al.Biorxiv : the Preprint Server for Biology|August 30, 2024
DNA damage response signatures are associated with frontline chemotherapy response and routes of tumor evolution in extensive stage small cell lung cancerBenjamin B Morris, Simon Heeke, Yuanxin Xi, et al.Molecular Cancer|March 21, 2025
DNA damage response signatures are associated with frontline chemotherapy response and routes of tumor evolution in extensive stage small cell lung cancerBenjamin B Morris, Simon Heeke, Yuanxin Xi, et al.Pageof 3